ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "epigenetics and phenotypes"

  • Abstract Number: 672 • 2016 ACR/ARHP Annual Meeting

    Sjogren Big Data Project: Influence of Geolocation on the Phenotypic Expression at Diagnosis in 8310 Patients (North-to-South Gradient)

    Pilar Brito-Zerón1,2, Soledad Retamozo3, Margit Zeher4, Astrid Rasmussen5, Raphaele Seror6, Elke Theander7, Xiaomei Li8, Chiara Baldini9, Jacques-Eric Gottenberg10, Debashish Danda11, Luca Quartuccio12, Roberta Priori13,14, Gabriela Hernandez-Molina15, Aike A. Kruize16, Valeria Valim17, Marika Kvarnström18, Damien Sene19, Roberto Gerli20, Sonja Praprotnik21, David A. Isenberg22, Roser Solans23, Maureen Rischmueller24, Seung-Ki Kwok25, Gunnel Nordmark26, Yasunori Suzuki27, Roberto Giacomelli28, Valerie Devauchelle29, Michele Bombardieri30, Benedikt Hofauer31, Hendrika Bootsma32, Johan G. Brun33, Guadalupe Fraile34, Steven E. Carsons35, Tamer Gheita36, Jacques Morel37, Cristina F. Vollenweider38, Fabiola Atzeni39, Nihan Acar-Denizli40, Ildike-Fanny Horvath4, Kathy Sivils5, Thomas Mandl41, Pulukool Sandhya11, Salvatore De Vita42, Jorge Sánchez-Guerrero43, Eefje van der Heijden16, Virginia Moça Trevisano44, Marie Wahren-Herlenius18, Xavier Mariette6, Manuel Ramos-Casals1,45,46 and EULAR-SS Task Force Big Data Consortium (ASSES, GEAS-SEMI, EULAR), 1Laboratory of Systemic Autoimmune Diseases “Josep Font”, CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Spain, Barcelona, Spain, 2Autoimmune Diseases Unit, Department of Medicine, Hospital CIMA- Sanitas, Barcelona., Bacelona, Spain, 3Rheumatology Unit, Hospital Privado Centro Médico de Córdoba, Argentina, Córdoba, Argentina, 4Division of Clinical Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Debrecen, Hungary, 5Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, USA, Oklahoma City, OK, 6Center for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, Université Paris Sud, INSERM, Paris, France, Paris, France, 7Department of Rheumatology, Malmö University Hospital, Lund University, Sweden, Malmö, Sweden, 8Department of Rheumatology and Immunology, Anhui Medical University Affiliated Provincial Hospital, China, Hefei, Anhui, China, 9Rheumatology Unit, University of Pisa, Italy, Pisa, Italy, 10Department of Rheumatology, Strasbourg University Hospital, Université de Strasbourg, CNRS, Strasbourg, France, Strasbourg, France, 11Clinical Immunology & Rheumatology, Christian Medical College, Vellore, India, Vellore, India, 12Rheumatology Clinic, DSMB, University of Udine, Udine, Italy, Udine, Italy, 13Rheumatology Unit, Sapienza University of Rome, Rome, Italy, 14Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy, 15Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico City, Mexico, 16Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands, Utrecht, Netherlands, 17Rheumatology, Department of Medicine, Universidade Federal do Espírito Santo, Vitória, Brazil, Vitória, Brazil, 18Department of Medicine, Solna, Unit of Experimental Rheumatology, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden, 19Service de Médecine Interne 2, Hôpital Lariboisière, Université Paris VII, Assistance Publique-Hôpitaux de Paris, 2, Paris, France, Paris, France, 20Clinical and Experimental Medicine, Rheumatology Unit, University of Perugia, Italy, Perugia, Italy, 21Department of Rheumatology, University Medical Centre Ljubljana, Slovenia, Ljubljana, Slovenia, 22Centre for Rheumatology, Division of Medicine, University College London, London, United Kingdom, 23Autoimmune Systemic Diseases Unit, Department of Internal Medicine, Hospital Vall d'Hebron, Autonomous University of Barcelona, Spain, Barcelona, Spain, 24Department of Rheumatology, School of Medicine, The University of Western Australia, Crawley, Australia, Crawley, Australia, 25Division of Rheumatology, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, Seoul, South Korea, 26Rheumatology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Sweden, Uppsala, Sweden, 27Division of Rheumatology, Kanazawa University Graduate School of Medicine, Ishikawa, Japan, Kanazawa, Japan, 28Clinical Unit of Rheumatology, University of l'Aquila, School of Medicine, L'Aquila, Italy, L'Aquila, Italy, 29Service de Rhumatologie, Department of Rheumatology, Brest University Hospital, Brest, France, Brest, France, 30Willian Harvey Research Institute, Centre for Experimental Medicine and Rheumatology, QMUL, UK, London, United Kingdom, 31Hals-Nasen-Ohrenklinik und Poliklinik, Technische Universität München, München, Germany, München, Germany, 32Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, The Netherlands, Groningen, Netherlands, 33Department of Clinical Science, University of Bergen. Department of Rheumatology, Haukeland University Hospital, Bergen, Norway, Bergen, Norway, 34Department of Internal Medicine, Hospital Ramón y Cajal, Madrid, Spain, Madrid, Spain, 35Division of Rheumatology, Allergy and Immunology Winthrop-University Hospital, Stony Brook University School of Medicine, NY, USA, Mineola, NY, 36Rheumatology, Rheumatology Department, Faculty of Medicine, Cairo University, Egypt, Cairo, Egypt, 37Department of Rheumatology, Teaching hospital and University of Montpellier, France, Montpellier, France, 38Rheumatology, German Hospital, Buenos Aires, Argentina, Buenos Aires, Argentina, 39IRCCS Galeazzi Orthopedic Institute, Milan, Italy, Milan, Italy, 40Department of Statistics, Faculty of Science and Letters, Mimar Sinan Fine Arts University, Turkey, Istabul, Turkey, 41Department of Clinical Sciences Malmö, Lund University, Skåne University Hospital, Rheumatology, Malmö, Sweden, Malmö, Sweden, 42Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital "Santa Maria della Misericordia", Udine, Italy, Udine, Italy, 43Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, Mexico, 44Federal University of São Paulo, Sao Paulo, Brazil, San Paulo, Brazil, 45Sjögren Syndrome Research Group (AGAUR), Barcelona, Spain, 46Department of Medicine, University of Barcelona, Barcelona, Spain., Barcelona, Spain

    Background/Purpose: To analyse the influence of geolocation (North-to-South gradient) on the clinical presentation of primary Sjögren syndrome (SjS) at diagnosis. Methods: The Big Data Sjögren…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology